| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
The primary targets of Desoxypeganine are butyrylcholinesterase (BChE), acetylcholinesterase (AChE), and monoamine oxidase A (MAO-A). Desoxypeganine is a potent and orally active cholinesterase inhibitor, acting preferentially on butyrylcholinesterase. It is also a selective inhibitor of MAO-A but not MAO-B. The compound crosses the blood-brain barrier and causes a pronounced depression of cholinesterase activity.
|
|---|---|
| ln Vitro |
In vitro, Desoxypeganine inhibits cholinesterase activity (BChE and AChE) and selectively inhibits MAO-A. It is a potent and orally active inhibitor. The compound is used as a reference alkaloid in cholinesterase and MAO research.
|
| ln Vivo |
In vivo, Desoxypeganine hydrochloride causes a pronounced depression of cholinesterase activity in animals. It is used for the treatment of patients with lesions of the peripheral nervous system. The compound is investigated for alcohol abuse. It crosses the blood-brain barrier.
|
| Enzyme Assay |
For non-cellular assays, cholinesterase activity is measured using acetylthiocholine or butyrylthiocholine as substrate and Ellman's reagent. Desoxypeganine is added at various concentrations, and the rate of thiocholine production is measured spectrophotometrically at 412 nm. MAO-A activity is measured using a fluorogenic substrate.
|
| Cell Assay |
For cell-based assays, cells expressing cholinesterase or MAO-A are treated with Desoxypeganine. Enzyme activity in cell lysates is measured using the fluorogenic substrate. Cell viability is assessed by MTT assay.
|
| Animal Protocol |
For in vivo experiments, Desoxypeganine is administered to rodents via oral or intraperitoneal routes. Cholinesterase activity in brain tissue is measured using the fluorogenic substrate. Behavioral effects are assessed in models of alcohol abuse and peripheral nerve lesions.
|
| References |
|
| Additional Infomation |
See also: Deoxypeganin (note moved to).
|
| Molecular Formula |
C11H12N2.HCL
|
|---|---|
| Molecular Weight |
208.69
|
| Exact Mass |
208.077
|
| CAS # |
61939-05-7
|
| Related CAS # |
495-59-0 (Parent)
|
| PubChem CID |
3046290
|
| Appearance |
Typically exists as solid at room temperature
|
| Boiling Point |
311.6ºC at 760 mmHg
|
| LogP |
2.501
|
| tPSA |
15.6
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
1
|
| Rotatable Bond Count |
0
|
| Heavy Atom Count |
14
|
| Complexity |
234
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C1=CC=C2C(=C1)CN3CCCC3=N2.Cl
|
| InChi Key |
KTCXMTWSISEJFZ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C11H12N2.ClH/c1-2-5-10-9(4-1)8-13-7-3-6-11(13)12-10;/h1-2,4-5H,3,6-8H2;1H
|
| Chemical Name |
1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline;hydrochloride
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.7918 mL | 23.9590 mL | 47.9180 mL | |
| 5 mM | 0.9584 mL | 4.7918 mL | 9.5836 mL | |
| 10 mM | 0.4792 mL | 2.3959 mL | 4.7918 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.